On design and inference for two-stage adaptive clinical trials with dependent data

Journal of Statistical Planning and Inference

Volumn 136, Issue 6, 2006, Pages 1962-1984

  Liu, Qing ^a   Pledger, Gordon ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Adaptive design; Conditional error function; Construct parameters; Multiple type I error rates; Overall p value; Sample size adjustment; Stochastic independence

Indexed keywords

EID: 32044434974     PISSN: 03783758     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jspi.2005.08.015     Document Type: Article

References (31)

1. P. Armitage Restricted sequential procedures Biometrika 44 1957 9-56
2. P. Armitage C.K. McPherson B.C. Rowe Repeated significance tests on accumulating data J. Roy. Statist. Soc. Ser. A 132 1969 235-244
3. P. Bauer M. Kieser Combing different phases in the development of medical treatments within a single trial Statist. Med. 18 1999 1833-1848
4. P. Bauer K. Köhne Evaluations of experiments with adaptive interim analyses Biometrics 50 1994 1029-1041
5. W. Brannath M. Posch P. Bauer Recursive combination tests J. Amer. Statist. Assoc. 97 2002 236-244
6. T.D. Cook P-value adjustment in sequential clinical trials Biometrics 58 2002 1005-1011
7. D.L. DeMets Stopping guidelines vs. stopping rules: A practitioner's point of view Comm. Statist. Part A - Theory Methods 13 1984 2395-2417
8. J.S. Denne Sample size recalculation using conditional power Statist. Med. 20 2001 2645-2660
9. C.W. Dunnett New tables for multiple comparisons with a control Biometrics 20 1964 482-491
10. L.D. Fisher Self-designing clinical trials Statist. Med. 17 1998 1551-1562
11. R.V. Hogg Adaptive methods S. Kotz N.L. Johnson Encyclopedia of Statistical Sciences vol. 1 1982 Wiley New York 20-24
12. G. Hommel Adaptive modifications of hypotheses after an interim analysis Biomed. J. 43 2001 581-589
13. C. Jennison B.W. Turnbull Group Sequential Methods with Applications to Clinical Trials 2000 Chapman & Hall London
14. K.K.G. Lan D.L. DeMets Discrete sequential boundaries for clinical trials Biometrika 70 1983 659-663
15. K.K.G. Lan D.M. Zucker Sequential monitoring of clinical trials: The role of information and Brownian motion Statist. Med. 12 1993 753-765
16. K.Y. Liang S.L. Zeger Longitudinal data analysis using generalized linear models Biometrika 73 1986 13-22
17. Q. Liu G.Y.H. Chi On sample size and inference for two-stage adaptive designs Biometrics 57 2001 172-177
18. Q. Liu Y. Li J.M. Boyett Controlling false positive rates in prognostic factor analyses with small samples Statist. Med. 16 1997 2095-2101
19. Q. Liu M.A. Proschan G.W. Pledger A unified theory of two-stage adaptive designs J. Amer. Statist. Assoc. 97 2002 1034-1041
20. R. Marcus E. Peritz K.R. Gabriel On closed testing procedures with special reference to ordered analysis of variance Biometrika 63 1976 655-660
21. P. McCullagh J.A. Nelder Generalized Linear Models 1989 Chapman & Hall New York
22. P.C. O'Brien Procedures for comparing samples with multiple endpoints Biometrics 40 1984 1079-1087
23. M.A. Proschan S.A. Hunsberger Designed extension of studies based on conditional power Biometrics 51 1995 1315-1324
24. M.A. Proschan Q. Liu S.A. Hunsberger Practical midcourse sample size modification in clinical trials Controlled Clin. Trials 24 2003 4-15
25. D.J. Schaid S. Wieand T.M. Therneau Optimal two-stage screening designs for survival comparisons Biometrika 77 1990 507-513
26. G.A.F. Seber Multivariate Observations 1984 Wiley New York
27. W.J. Shih P. Ouyang H. Quan Y. Lin B. Michiels L. Bijnens Controlling type I error rate for fast track drug development programmes Statist. Med. 22 2003 665-675
28. P.F. Thall R. Simon S.S. Ellenberg Two-stage selection and testing designs for comparative clinical trials Biometrika 75 1988 303-310
29. A.A. Tsiatis G.L. Rosner C.R. Mehta Exact confidence intervals following a group sequential test Biometrics 40 1984 797-803
30. L.J. Wei D.Y. Lin L. Weissfeld Regression analysis of multivariate incomplete failure time data by modeling marginal distributions J. Amer. Statist. Assoc. 84 1989 1065-1073
31. J. Whitehead Sample sizes for phase II and phase III clinical trials: An integrated approach Statist. Med. 5 1986 459-464